Gemtuzumab Ozogamicin in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study

Richard F. Schlenk, Hartmut Döhner, Uwe M. Martens et al.|Journal of Clinical Oncology|2019

Cited by 111